Fundamentals-based quality & risk · not a recommendation
Raw blend 64 capped to 40 by a red flag.
Raw blend 64 → capped to 40
CNL scores 40/100 (Caution) on the Orion Score — moderate business quality (58), strong growth (93) and weak balance-sheet safety (47). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
75/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹740.01 | ₹17.79 | 4.0% | ₹10.74 |
| Q3 2026 | ₹911.79 | ₹23.37 | 2.9% | ₹13.52 |
| Q2 2026 | ₹655.01 | ₹18.95 | 3.4% | ₹10.85 |
| Q1 2026 | ₹392.96 | ₹8.89 | 3.0% | ₹5.92 |
| Q4 2025 | ₹402.99 | ₹13.73 | 3.6% | ₹8.40 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹1,774.48 | ₹46.21 | ₹70.63 | 3.0% |
| FY 2024 | ₹1,713.12 | ₹44.06 | ₹66.8 | 2.8% |
| FY 2023 | ₹1,392.76 | ₹24.59 | ₹43.41 | 2.5% |
| FY 2022 | ₹947.04 | ₹15.99 | ₹31.06 | 3.3% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹531.75 | ₹361.38 | ₹287.98 | ₹253.14 |
| Equity | ₹294.01 | ₹215.71 | ₹117.4 | ₹82.27 |
| Total Debt | ₹71.8 | ₹73.56 | ₹88.93 | ₹64.35 |
| Cash | ₹43.88 | ₹7.2 | ₹2.59 | ₹2.86 |
| Net Debt | ₹27.93 | ₹66.36 | ₹86.35 | ₹61.49 |
| Working Capital | ₹298.93 | ₹223.24 | ₹126.23 | ₹88.96 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 70.33% | 0% | 0% | 29.67% |
| Q4 FY2026 | 70.33% ↑ | 0% ↓ | 0% ↓ | 29.67% ↓ |
| Q3 FY2026 | 56.62% | 0.22% ↓ | 1.04% ↑ | 42.12% ↑ |
| Q2 FY2026 | 56.62% ↑ | 0.37% ↓ | 0.98% ↑ | 42.03% ↑ |
| Q1 FY2026 | 56.6% | 1.01% ↑ | 0.96% | 41.43% ↓ |
| Q4 FY2025 | 56.6% ↑ | 0.98% ↑ | 0.96% ↓ | 41.47% ↑ |
| Q3 FY2025 | 56.16% | 0.89% ↑ | 1.52% | 41.43% ↓ |
| Q2 FY2025 | 56.16% | 0.29% | 1.52% | 42.02% |
No recent corporate actions
Ask: "Is CNL stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.